Jason Redman

9PUBLICATIONS
45CO-AUTHORS
Molecular targetsDeep learningApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Mechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 24, 2026
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

|Jul 03, 2024
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

Danh-Tai Hoang, Gal Dinstag, Eldad D Shulman

|Jun 13, 2023
Avelumab in Patients With Metastatic Colorectal Cancer.

Jason M Redman, Geraldine O'Sullivan Coyne, Clay T Reed

|Jan 14, 2023
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.

Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss

|Mar 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.

Jason M Redman, Yo-Ting Tsai, Benjamin A Weinberg

|Sep 04, 2021
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.

Peter J DeMaria, Katherine Lee-Wisdom, Renee N Donahue

Pageof 2

Frequent Collaborators

5 joint publications

Jeffrey Schlom

5 joint publications

James L Gulley

4 joint publications

Lisa Cordes

3 joint publications

Margaret E Gatti-Mays